| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL1438 | Name | ULK4P2 | Aliases | D-X; FAM7A2 | |
| Species | Homo sapiens | Chromosome | 15 | Start site | 30572738 | |
| End site | 30600647 | Chain | plus | Exon NO. | 5 | |
| Assembly | Ensembl Release 89 | Class | processed transcript | NCBI accession | NR_027470 | |
| Ensembl | ENSG00000260128 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| hepatocelluar carcinoma | microarray, qPCR etc. | HBV-related HCC tissue | up-regulated | interaction | Four upregulated lncRNAs were randomly selected and analyzed for their expression levels in tissue samples from 14 HBV-related HCC patients. The corresponding non-tumor tissues were analyzed via qPCR, in which the obtained results are consistent with the microarray data. The upregulated large intergenic noncoding RNA ULK4P2 was physically combined with enhancer of zeste homolog 2. Therefore, the lncRNAs may participate in regulating HBV-related HCC. | 26109807 | Lnc2Cancer | ||
| Interaction | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
| enhancer of zeste homolog 2 | RNA-DNA | binding | The upregulated large intergenic noncoding RNA ULK4P2 was physically combined with enhancer of zeste homolog 2. | 26109807 | |||||